Sustainability
Unser Ziel ist es, unser Geschäft zu transformieren, um ein weltweit führendes Unternehmen im Bereich der nachhaltigen Gesundheitsversorgung zu werden
Revolutionierung der Pflege
Ethisches Wirtschaften
Wir setzen hohe Standards in Bezug auf Ethik und Verantwortung in unserem Unternehmen und handeln in unserer gesamten Wertschöpfungskette mit Integrität und Fürsorge für die Menschenrechte.
-
Materiality analysis
Mölnlycke reviews a materiality analysis at least every second year to identify which issues to prioritise, manage and monitor to create shared value for society, the environment and the economy, as well as identify future challenges and opportunities for the company. In the 2022 materiality analysis, various stakeholders, including Mölnlycke’s employees, customers, distributors, suppliers, national sector organisations and students helped to identify 20 material aspects that were of primary importance, and prepared the ground for the company’s WeCare roadmap.
The results showed that topics such as decent safe employment, diversity equity and inclusion, waste and circularity, sustainable innovation and development, and community support gained importance compared to the last materiality analysis in 2020. Other material aspects, such as biodiversity and responsible taxation approach, were found to have a lower significance.
In 2023 Mölnlycke started to prepare for the Corporate Sustainability Reporting Directive (CSRD) and Corporate Sustainability Due Diligence Directive (CS3D) implementation by performing a Double Materiality assessment and consequent gap analysis
evaluation.
"Angesichts des tiefgreifenden und anhaltenden Drucks, der auf der Umwelt, der Gesellschaft und insbesondere den globalen Gesundheitssystemen lastet, beschleunigt Mölnlycke unsere Transformation, um nachhaltige Gesundheitslösungen anzubieten. Wir sind einzigartig positioniert, um das Leben der Patienten zu verbessern und gleichzeitig die Umweltauswirkungen des Gesundheitswesens zu reduzieren."
Zlatko Rihter Vorsitzender der Geschäftsführung
Our commitment to reach Net Zero by 2050
Wir haben unsere Bemühungen zur Eindämmung des Klimawandels formalisiert, indem wir uns öffentlich zur Science Based Targets Initiative (SBTi) bekannt und die Validierung unserer kurzfristigen Klimaziele sichergestellt haben, die im Folgenden aufgeführt sind:
-
Reducing absolute scope 1 and 2 Greenhouse gas (GHG) emissions
Reducing absolute scope 1 and 2 GHG emissions by 50% by 2030 from a 2021 base year.
-
Increasing active annual sourcing of renewable electricity
Increasing active annual sourcing of renewable electricity from 23% in 2021 to 100% by the end of 2024 and continuing active annual sourcing of 100% of renewable electricity through 2030.
-
Reducing absolute scope 3 GHG emissions
Reducing absolute scope 3 GHG emissions from purchased goods and services (cat. 1), fuel and energy related activity (cat. 3), upstream transportation and distribution (cat. 4) and waste generated in operations (cat. 5) by 20% by 2028 from a 2021 base year.
-
Supplier engagement
Having 63% of our suppliers by emissions covering purchased goods and services (cat. 1) capital goods (cat. 2), and upstream transportation and distribution (cat. 4) committed to the Science Based Targets Initiative by 2028.
Milestones on the way to Net Zero
2016: Scope 1 and 2 GHG emissions measured and baseline established.
2021: Materiality analysis and development of WeCare (2030 sustainability roadmap).
2021: Upstream and downstream scope 3 GHG emissions measured and baseline established.
2021: First range of BARRIER® surgical drapes launched with demonstrable reductions in emissions.
2022: Commitment to SBTi and nine manufacturing sites operating on 100% fossil-free electricity.
2023: Validation of near-term GHG emission reduction targets by SBTi.
2023: Sustainable Product Portfolio Assessment conduced for Operation Room Solutions and Antiseptics portfolios.
2024: 100% renewable electricity at all manufacturing sites and the headqarters
Neuigkeiten aus der Nachhaltigkeit
See all news-
Mölnlycke Health Care wins Swedish Sustainability Tech award
Mölnlycke is proud to announce that it has been awarded the Capgemini Swedish Sustainability Tech Award 2024 for Mölnlycke ProcedurePak® trays. This accolade recognises the company’s innovative practices and dedication to revolutionise healthcare for people and planet.
-
Mölnlycke Health Care and Operation Smile help to change people's lives with newly inaugurated cleft care centre in Philippines
The centre is expected to serve 10,000 patients in the region with transformative cleft care in the first three years of operations.
-
Mölnlycke sets sail with ocean biofuel: A step towards greener logistics
-
Mölnlycke to help establish cleft care centre in the Philippines
World-leading medical solutions company Mölnlycke is setting up a centre for cleft care in the Philippine city of Cebu with its long-term charity partner Operation Smile.
-
Designing for circularity important for climate-smart healthcare
Mölnlycke strives to be at the forefront of driving decarbonisation of the healthcare sector. In December 2024, we were featured in Dagens Medicin’s campaign focused on sustainable healthcare. Caterina Camerani, VP Sustainability at Mölnlycke, explained how Mölnlycke can contribute to reducing climate impact of healthcare in general, and Operating Room in particular.
-
Mölnlycke awarded a Platinum medal from EcoVadis in 2024
-
In 2023 Mölnlycke was awarded a gold medal for Sustainability by EcoVadis
The world’s largest and most trusted provider of business sustainability ratings - EcoVadis, has awarded Mölnlycke a gold medal for our focus on sustainability. They have ranked us in the top 3% of companies worldwide.
-
Mölnlycke integrated Annual Report 2023
Today we are delighted to announce the launch of the Mölnlycke integrated Annual Report 2023. Our dedication to revolutionising care for people and planet contributed to a very successful year with record high annual net sales of EUR 1,924 million and substantial improvements in profitability. We continue to report our sustainability achievements in accordance with the Global Reporting Initiative (GRI) standards.
-
Mölnlycke Health Care reaches 100% renewable electricity target
Mölnlycke, a world leading MedTech company, has secured 100% renewable electricity for all its established and new manufacturing sites and its headquarters, reaching its first near-term SBTi (Science Based Targets initiative)-validated target.